Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
200 | 3 | ONCOLOGY//PACLITAXEL//THYMIDYLATE SYNTHASE | 52806 |
1497 | 2 | CISPLATIN//ISOLATED LIMB PERFUSION//IFOSFAMIDE | 7807 |
5967 | 1 | IFOSFAMIDE//MESNA//TROFOSFAMIDE | 1580 |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | IFOSFAMIDE | authKW | 1782242 | 18% | 31% | 292 |
2 | MESNA | authKW | 808240 | 5% | 51% | 79 |
3 | TROFOSFAMIDE | authKW | 408572 | 2% | 79% | 26 |
4 | OXAZAPHOSPHORINES | authKW | 356877 | 2% | 62% | 29 |
5 | BNP7787 | authKW | 319130 | 1% | 100% | 16 |
6 | CHLOROACETALDEHYDE | authKW | 299513 | 2% | 52% | 29 |
7 | GLUFOSFAMIDE | authKW | 283668 | 1% | 89% | 16 |
8 | CYCLOPHOSPHAMIDE | authKW | 221295 | 13% | 5% | 209 |
9 | ISOPHOSPHORAMIDE MUSTARD | authKW | 181322 | 1% | 91% | 10 |
10 | 4 HYDROXYCYCLOPHOSPHAMIDE | authKW | 141958 | 1% | 65% | 11 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Oncology | 10295 | 42% | 0% | 668 |
2 | Pharmacology & Pharmacy | 5400 | 35% | 0% | 552 |
3 | Chemistry, Medicinal | 738 | 7% | 0% | 112 |
4 | Toxicology | 494 | 6% | 0% | 95 |
5 | Chemistry, Analytical | 350 | 8% | 0% | 124 |
6 | Pediatrics | 220 | 5% | 0% | 80 |
7 | Urology & Nephrology | 205 | 4% | 0% | 64 |
8 | Biochemical Research Methods | 142 | 4% | 0% | 65 |
9 | Hematology | 133 | 4% | 0% | 57 |
10 | Medicine, Research & Experimental | 30 | 3% | 0% | 46 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | NIOMECH | 59837 | 0% | 100% | 3 |
2 | CIHR GSK CHAIR PAEDIAT CLIN PHARMACOL | 45326 | 0% | 45% | 5 |
3 | KRIGO | 44876 | 0% | 75% | 3 |
4 | CLIN PHARMACOL TOXICOL PHARMACOKINET | 39891 | 0% | 100% | 2 |
5 | METAB MALAD METAB U820 | 26593 | 0% | 67% | 2 |
6 | ALLOGENE STEM CELL TRANSPLANTA | 19946 | 0% | 100% | 1 |
7 | CANC TRIALSUNIT | 19946 | 0% | 100% | 1 |
8 | CATEDRA FARMACOL PHYSIOL | 19946 | 0% | 100% | 1 |
9 | CC17 | 19946 | 0% | 100% | 1 |
10 | CCS FISIOL FARMACOL HLTH SCI | 19946 | 0% | 100% | 1 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER CHEMOTHERAPY AND PHARMACOLOGY | 38270 | 8% | 2% | 120 |
2 | CANCER TREATMENT REVIEWS | 5207 | 1% | 1% | 23 |
3 | SEMINARS IN ONCOLOGY | 4907 | 2% | 1% | 36 |
4 | JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY | 3824 | 2% | 1% | 31 |
5 | ANTI-CANCER DRUGS | 3397 | 2% | 1% | 24 |
6 | NORTH DAKOTA COOPERATIVE EXTENSION SERVICE CIRCULAR | 3323 | 0% | 17% | 1 |
7 | DRUG METABOLISM AND DISPOSITION | 2983 | 2% | 0% | 34 |
8 | INVESTIGATIONAL NEW DRUGS | 2744 | 1% | 1% | 19 |
9 | MEDICAL AND PEDIATRIC ONCOLOGY | 2555 | 1% | 1% | 18 |
10 | CANCER RESEARCH | 2318 | 4% | 0% | 69 |
Author Key Words |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass | LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | IFOSFAMIDE | 1782242 | 18% | 31% | 292 | Search IFOSFAMIDE | Search IFOSFAMIDE |
2 | MESNA | 808240 | 5% | 51% | 79 | Search MESNA | Search MESNA |
3 | TROFOSFAMIDE | 408572 | 2% | 79% | 26 | Search TROFOSFAMIDE | Search TROFOSFAMIDE |
4 | OXAZAPHOSPHORINES | 356877 | 2% | 62% | 29 | Search OXAZAPHOSPHORINES | Search OXAZAPHOSPHORINES |
5 | BNP7787 | 319130 | 1% | 100% | 16 | Search BNP7787 | Search BNP7787 |
6 | CHLOROACETALDEHYDE | 299513 | 2% | 52% | 29 | Search CHLOROACETALDEHYDE | Search CHLOROACETALDEHYDE |
7 | GLUFOSFAMIDE | 283668 | 1% | 89% | 16 | Search GLUFOSFAMIDE | Search GLUFOSFAMIDE |
8 | CYCLOPHOSPHAMIDE | 221295 | 13% | 5% | 209 | Search CYCLOPHOSPHAMIDE | Search CYCLOPHOSPHAMIDE |
9 | ISOPHOSPHORAMIDE MUSTARD | 181322 | 1% | 91% | 10 | Search ISOPHOSPHORAMIDE+MUSTARD | Search ISOPHOSPHORAMIDE+MUSTARD |
10 | 4 HYDROXYCYCLOPHOSPHAMIDE | 141958 | 1% | 65% | 11 | Search 4+HYDROXYCYCLOPHOSPHAMIDE | Search 4+HYDROXYCYCLOPHOSPHAMIDE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |